These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22744330)

  • 1. [Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda].
    Niessen C; Jung EM; Stroszczynski C; Wiggermann P
    Rofo; 2012 Oct; 184(10):937-8. PubMed ID: 22744330
    [No Abstract]   [Full Text] [Related]  

  • 2. Detecting curable disease following hepatectomy for colorectal metastases.
    Metcalfe M; Mann C; Mullin E; Maddern G
    ANZ J Surg; 2005 Jul; 75(7):524-7. PubMed ID: 15972037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation for focal ablation at the porta hepatis.
    Kasivisvanathan V; Thapar A; Oskrochi Y; Picard J; Leen EL
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1531-4. PubMed ID: 22367010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
    Stapel A; Franke U; Putzki H
    Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report.
    Bagla S; Papadouris D
    J Vasc Interv Radiol; 2012 Jan; 23(1):142-5. PubMed ID: 22221480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of second-look operations in colorectal cancer].
    Saitoh N; Miyazaki M; Sarashina H; Nunomura M; Yokoyama M; Inoue I; Ihara M; Nakayama H; Oda N; Shirai Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1289-94. PubMed ID: 2471456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Control of recurrence with CEA and CT after colon cancer operation].
    Holzgreve H
    MMW Fortschr Med; 2014 Feb; 156(2):33. PubMed ID: 24934047
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatectomy for liver metastasis from ampullary cancer after pancreatoduodenectomy.
    Yoshida T; Matsumoto T; Sasaki A; Bandoh T; Kawano K; Kitano S; Gotanda T
    Hepatogastroenterology; 2002; 49(43):247-8. PubMed ID: 11941966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrence of gastric cancer].
    Matsukawa M; Kouda T; Hiratsuka N; Wada M; Takebuchi K; Kurihara M
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():238-42. PubMed ID: 11424384
    [No Abstract]   [Full Text] [Related]  

  • 13. [After-care of colorectal carcinoma--value of tumor markers].
    Köhne CH; Benter T
    Internist (Berl); 1997 Apr; 38(4):363-5. PubMed ID: 9213578
    [No Abstract]   [Full Text] [Related]  

  • 14. Is ultrasound superior to carcinoembryonic antigen (CEA) measurement in recurrent tumor screening of patients with colorectal carcinoma?
    Stautner-Brückmann C; Schneider W; Gresser U; Richter-Turtur M; Eibl-Eibesfeld B; Zoller WG; Zöllner N
    Bildgebung; 1990; 57(1-2):17-20. PubMed ID: 2271809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases.
    Kijima M; Togo S; Ichikawa Y; Miura M; Yamagishi S; Matsuo K; Tanaka K; Masui H; Ishikawa T; Ike H; Shimada H
    Anticancer Res; 2005; 25(2B):1327-32. PubMed ID: 15865086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
    Lencioni R; Crocetti L; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sense and nonsense in after-care of colorectal carcinoma].
    Schölmerich J
    Med Klin (Munich); 1996 Jun; 91(6):420-7. PubMed ID: 8767320
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.
    Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL
    Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.